menu
    • menu
    [{"orgOrder":0,"company":"Kappa Bioscience","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"NETHERLANDS","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2023","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Kappa Bioscience","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Oil","sponsorNew":"Kappa Bioscience \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"Kappa Bioscience \/ Kappa Bioscience"},{"orgOrder":0,"company":"Kappa Bioscience","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"NETHERLANDS","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2021","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Infections and Infectious Diseases","graph2":"Undisclosed","graph3":"Kappa Bioscience","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kappa Bioscience \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"Kappa Bioscience \/ Kappa Bioscience"},{"orgOrder":0,"company":"Kappa Bioscience","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"UNITED KINGDOM","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2020","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Immunology","graph2":"Undisclosed","graph3":"Kappa Bioscience","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kappa Bioscience \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"Kappa Bioscience \/ Kappa Bioscience"},{"orgOrder":0,"company":"Kappa Bioscience","sponsor":"Kappa Bioscience","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"KUWAIT","productType":"Vitamins\/Minerals\/Inorganic Salts","year":"2022","type":"Inapplicable","leadProduct":"Vitamin K2","moa":"Trypanosoma Cruzipain (Trypano CYSP)","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Kappa Bioscience","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Kappa Bioscience \/ Kappa Bioscience","highestDevelopmentStatusID":"1","companyTruncated":"Kappa Bioscience \/ Kappa Bioscience"}]

    Find Clinical Drug Pipeline Developments & Deals by Kappa Bioscience

    Menu

    Kappa Bioscience

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Kappa Bioscience

                            Norway arrow
                            AAPS
                            Not Confirmed

                            Kappa Bioscience

                            Norway arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Vitamin K2

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Recipient : NIZO Food Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Antioxidant and Immune Effects of Vitamin K2

                            Details : Vitamin K2 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Oxidative Stress.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            January 09, 2023

                            Lead Product(s) : Vitamin K2

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Recipient : NIZO Food Research

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Kappa Bioscience

                            Norway arrow
                            AAPS
                            Not Confirmed

                            Kappa Bioscience

                            Norway arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Vitamin K2

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Recipient : Dasman Diabetes Institute

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Vitamin K2 and Muscle Weakness in Type 2 Diabetes

                            Details : Vitamin K2 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus, Type 2.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            May 16, 2022

                            Lead Product(s) : Vitamin K2

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Recipient : Dasman Diabetes Institute

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Kappa Bioscience

                            Norway arrow
                            AAPS
                            Not Confirmed

                            Kappa Bioscience

                            Norway arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Vitamin K2

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Undisclosed

                            Recipient : Canisius-Wilhelmina Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19

                            Details : Vitamin K2 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of COVID-19.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            February 25, 2021

                            Lead Product(s) : Vitamin K2

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Undisclosed

                            Recipient : Canisius-Wilhelmina Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Kappa Bioscience

                            Norway arrow
                            AAPS
                            Not Confirmed

                            Kappa Bioscience

                            Norway arrow
                            AAPS
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Vitamin K2

                            Therapeutic Area : Immunology

                            Study Phase : Undisclosed

                            Recipient : University of Glasgow

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            viTAmin K2 and rEcOVery From ExeRcise

                            Details : Vitamin K2 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Inflammation.

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            December 21, 2020

                            Lead Product(s) : Vitamin K2

                            Therapeutic Area : Immunology

                            Highest Development Status : Undisclosed

                            Recipient : University of Glasgow

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth